Skip to content

Observation on the clinical effect of acupuncture treatment of diabetes with mother-child reinforcing-reducing method

Observation on the clinical effect of acupuncture treatment of diabetes with mother-child reinforcing-reducing method

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039047
Enrollment
Unknown
Registered
2020-10-14
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Sponsors

Shandong University Of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Comply with the diagnostic criteria of western medicine in the "Guidelines for the Prevention and Treatment of Type 2 Diabetes in China"; 2. Meet the TCM diagnostic criteria for Yin deficiency syndrome of Diabetes; 3. Age between 20-60 years old; 4. No contraindications to acupuncture; 5. The inspection indicators meet the indications for treatment; 6. The patient has the right to know, and the patient is willing to receive treatment and has good compliance.

Exclusion criteria

Exclusion criteria: 1. Acute complications such as diabetic ketoacidosis, hyperglycemia and hyperosmolar state, or combined with other serious primary diseases; 2. Patients with liver and kidney dysfunction; 3. Patients with dementia or mental illness; 4. Patients with other infections; 5. Women during pregnancy and lactation; 6. Patients with Type 1 diabetes; 7. Those who have contraindications to acupuncture.

Design outcomes

Primary

MeasureTime frame
blood glucose;Glycated hemoglobin;Changes in patient symptoms and signs;Treatment completion Rate;

Countries

China

Contacts

Public ContactYiyang Sun

Shandong University of Traditional Chinese Medicine

beibei_05@sina.cn+86 15908999599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026